Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Verona Pharma Plc ADR (VRNA)

Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Verona Pharma Plc ADR 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE GBR

www.veronapharma.com Employees: 79 P: 44-20-3283-4200

Description:

Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 3,380,089
Enterprise Value, $K 3,156,689
Shares Outstanding, K 80,440
Annual Sales, $ 0 K
Annual Net Income, $ -54,370 K
Last Quarter Sales, $ 5,620 K
Last Quarter Net Income, $ -42,960 K
EBIT, $ -155,380 K
EBITDA, $ -154,590 K
60-Month Beta 0.46
% of Insider Shareholders 4.80%
% of Institutional Shareholders 85.88%
Float, K 76,579
% Float 95.20%
Short Volume Ratio 0.35

Growth:

1-Year Return 153.44%
3-Year Return 554.52%
5-Year Return 545.47%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 64.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.56 on 11/04/24
Next Earnings Date N/A
Earnings Per Share ttm -1.92
EPS Growth vs. Prev Qtr 36.36%
EPS Growth vs. Prev Year -211.11%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VRNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -79.54%
Return-on-Assets % -43.49%
Profit Margin % 0.00%
Debt/Equity 0.92
Price/Sales 604.87
Price/Cash Flow N/A
Price/Book 25.85
Book Value/Share 1.59
Interest Coverage -25.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar